Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
Thank you for tuning in, and I look forward to addressing more questions and topics in future episodes
Telehealth has revolutionized access to weight loss medications by eliminating geographic barriers, reducing costs, and streamlining the process from consultation to delivery
Annual checkups, screenings, and vaccines can go a long way in protecting your health and catching issues early
Slawinski, C
Similar effects were exerted by Exendin-4 [72]
